Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy. | Cancers (Basel) | 2025 | 40361480 | PubTator, text mining | PubMed |
| ProOvErlap: Assessing feature proximity/overlap and testing statistical significance from genomic intervals. | J Biol Chem | 2025 | 40345582 | PubTator, text mining | PubMed |
| Advances in Mechanochemical Methods for One-Pot Multistep Organic Synthesis. | Chemistry | 2025 | 40327599 | PubTator, text mining | PubMed |
| Identification of pyrazole scaffold inhibitors targeting cyclin-dependent kinase 8 for potential use in pulmonary fibrosis. | Biochem Pharmacol | 2025 | 40280247 | PubTator, text mining | PubMed |
| The role of CDK8 gene polymorphisms in bladder cancer susceptibility and prognosis: a study in the Chinese Han population. | BMC Cancer | 2025 | 40241036 | PubTator, text mining | PubMed |
| UTERINE FIBROIDS. | Physiol Rev | 2025 | 40214304 | PubTator, text mining | PubMed |
| Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer. | Transl Oncol | 2025 | 40163908 | PubTator, text mining | PubMed |
| Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma. | Cancers (Basel) | 2025 | 40149277 | PubTator, text mining | PubMed |
| Chemical composition and anticancer activity of Psychotria montana on MCF7 breast cancer cells: insights from in vitro (2D & 3D) studies and in silico analysis. | J Appl Biomed | 2025 | 40145882 | PubTator, text mining | PubMed |
| A Protocol to Purify Human Mediator Complex From Freestyle 293-F Cells. | Bio Protoc | 2025 | 40028032 | PubTator, text mining | PubMed |
| IMERGE-FEP: Improving Relative Free Energy Calculation Convergence with Chemical Intermediates. | J Phys Chem B | 2025 | 39976528 | PubTator, text mining | PubMed |
| An Effective Reaction-Based Virtual Screening Method to Discover New CDK8 Ligands. | ChemMedChem | 2025 | 39972506 | PubTator, text mining | PubMed |
| Association of CDK8 Gene Polymorphisms with Cervical Cancer in Han Women in Southwest China. | Genet Test Mol Biomarkers | 2025 | 39964205 | PubTator, text mining | PubMed |
| Structural optimization and biological evaluation of indolin-2-one derivatives as novel CDK8 inhibitors for idiopathic pulmonary fibrosis. | Biomed Pharmacother | 2025 | 39955852 | PubTator, text mining | PubMed |
| Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome. | Elife | 2025 | 39928031 | PubTator, text mining | PubMed |
| Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth. | Nat Immunol | 2025 | 39891018 | PubTator, text mining | PubMed |
| Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male Mice. | Biol Psychiatry Glob Open Sci | 2025 | 39830600 | PubTator, text mining | PubMed |
| The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In Vivo. | Int J Biol Sci | 2025 | 39781457 | PubTator, text mining | PubMed |
| Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors. | J Med Chem | 2025 | 39780505 | PubTator, text mining | PubMed |
| Identification of a Potent CDK8 Inhibitor Using Structure-Based Virtual Screening. | J Chem Inf Model | 2025 | 39740163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=5